Clincosm LogoSign in Get a demo

Lymphoma, Non-Hodgkin

Showing 51 - 75 of 259
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Worldwide (Relatlimab, Nivolumab)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin Disease
  • Phoenix, Arizona
  • +53 more
Aug 17, 2022

Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia Trial in Worldwide (JNJ-64264681, JNJ-67856633)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Chronic Lymphocytic Leukemia
  • Stony Brook, New York
  • +27 more
Aug 11, 2022

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-80948543)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Duarte, California
  • +18 more
Aug 11, 2022

Lymphoma, Non-Hodgkin Trial in Worldwide (CC-99282, Obinutuzumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Boston, Massachusetts
  • +17 more
Aug 1, 2022

Biospecimen Procurement for Center for Immuno-Oncology

Recruiting
  • Multiple Myeloma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 13, 2022

    Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in Milwaukee (CAR-20/19-T cells (1.0 x10^5

    Completed
    Has Results
    • Lymphoma, Non-Hodgkin
    • +3 more
    • CAR-20/19-T cells (1.0 x10^5 CAR-20/19-T cells/kg)
    • +3 more
    • Milwaukee, Wisconsin
      Froedtert Hospital & Medical College of Wisconsin
    Jun 26, 2022

    Lymphoma, Non-Hodgkin Trial in Secaucus (DZD8586, Placebo)

    Completed
    • Lymphoma, Non-Hodgkin
    • Secaucus, New Jersey
      Frontage Clinical Service 200 Meadowlands Parkway
    Jul 8, 2022

    Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)

    Not yet recruiting
    • Lymphoma, Mantle-Cell
    • +7 more
    • (no location specified)
    Jun 21, 2022

    Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid

    Active, not recruiting
    • Mycoses
    • +5 more
    • anti-thymocyte globulin
    • +2 more
    • Stanford, California
      Stanford University School of Medicine
    Jun 16, 2022

    Allogeneic Gamma Delta (?d) CAR T Cells

    Enrolling by invitation
    • Lymphoma, Follicular
    • +5 more
    • ADI-001
    • Stanford, California
    • +4 more
    Jun 7, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

    Recruiting
    • Acute Myeloid Leukemia
    • +12 more
    • Los Angeles, California
    • +6 more
    Jun 1, 2022

    Young Adults, Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Clermont-Ferrand (Indirect calorimetric test during submaximal

    Recruiting
    • Young Adults
    • +2 more
    • Indirect calorimetric test during submaximal exercise
    • Clermont-Ferrand, France
      CHU de Clermont-Ferrand
    May 3, 2022

    Advanced Solid Tumor, NSCLC, Melanoma Trial in United States (AB308, Zimberelimab)

    Recruiting
    • Advanced Solid Tumor
    • +9 more
    • Phoenix, Arizona
    • +20 more
    May 2, 2022

    Lymphoma, Non-Hodgkin, Lymphoma, Nonhodgkin, Lymphoma, B-Cell Trial in United States (lisocabtagene maraleucel)

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • +3 more
    • lisocabtagene maraleucel
    • Gilbert, Arizona
    • +40 more
    Apr 22, 2022

    Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +3 more
      • Hot Springs, Arkansas
      • +12 more
      Apr 14, 2022

      Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

      Enrolling by invitation
      • Lymphoma, B-Cell
      • +4 more
      • Burbank, California
      • +90 more
      Mar 31, 2022

      Lymphoma, Non-Hodgkin Trial in Mainz (Obinutuzumab and Pixantrone)

      Completed
      • Lymphoma, Non-Hodgkin
      • Obinutuzumab and Pixantrone
      • Mainz, RLP, Germany
        Department of Hematology, Oncology and Pneumology; University Me
      Mar 30, 2022

      Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 cells)

      Active, not recruiting
      • Hodgkin Disease
      • +8 more
      • ATLCAR.CD30 cells
      • Chapel Hill, North Carolina
      • +1 more
      Mar 2, 2022

      Lymphoma, Non-Hodgkin Trial in Worldwide (Copanlisib (Aliqopa, BAY80-6946))

      Active, not recruiting
      Has Results
      • Lymphoma, Non-Hodgkin
      • Copanlisib (Aliqopa, BAY80-6946)
      • Birmingham, Alabama
      • +100 more
      Feb 10, 2022

      Lymphoma, Non-Hodgkin Trial in Canada, United States (TAK-659, Bendamustine, Rituximab)

      Terminated
      Has Results
      • Lymphoma, Non-Hodgkin
      • Tucson, Arizona
      • +12 more
      Dec 7, 2021

      Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin Trial (intervention)

      Not yet recruiting
      • Lymphoma, Non-Hodgkin
      • Lymphoma, Hodgkin
      • intervention
      • (no location specified)
      Feb 9, 2022

      Lymphoma, Non-Hodgkin Trial in France, Spain (CC-95775)

      Completed
      • Lymphoma, Non-Hodgkin
      • Paris, France
      • +4 more
      Jan 31, 2022

      Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)

      Recruiting
      • Lymphoma, Non-Hodgkin
      • +9 more
      • NKX019
      • Denver, Colorado
      • +6 more
      Jan 19, 2022

      Lymphoma, Non-Hodgkin Trial in United States (Hematopoietic Stem Cell Transplant)

      Completed
      Has Results
      • Lymphoma, Non-Hodgkin
      • Hematopoietic Stem Cell Transplant
      • Duarte, California
      • +20 more
      Dec 7, 2021

      Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin Trial in Ann Arbor (Bortezomib, Ruxolitinib)

      Completed
      • Hodgkin's Lymphoma
      • Lymphoma, Non-Hodgkin
      • Ann Arbor, Michigan
        University of Michgan Comprehensive Cancer Center
      Dec 3, 2021